Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

dailystar.co.uk - Kate Nelson - Big pharma bosses warn Europe will miss out on lifesaving meds to China and US
Big pharma bosses warn Europe will miss out on lifesaving meds to China and US
Daily Star –

Drug giants have warned Europe risks missing out on lifesaving new medicines unless governments act fast to stop investment fleeing overseas. Bosses at nine of the world's biggest pharmaceutical firms, including British giants GSK and AstraZeneca…

fool.com - Brendan Coffey - AbbVie vs. Eli Lilly: Which Star Pharma Stock Is a Better Buy in 2026?
AbbVie vs. Eli Lilly: Which Star Pharma Stock Is a Better Buy in 2026?
The Motley Fool –

Choosing between AbbVie (ABBV +0.01%) and Eli Lilly and Co (LLY +2.69%) requires weighing established income against explosive growth. Both companies lead the pharmaceutical space, but their paths for 2026 diverge significantly. AbbVie is…

newswire.ca - Sun Pharma Canada Inc. - Sun Pharma Launches (C)Taro-Methylphenidate ER, the First and Only Bioequivalent to Concerta with an Osmotic Delivery System
Sun Pharma Launches (C)Taro-Methylphenidate ER, the First and Only Bioequivalent to Concerta with an Osmotic Delivery System
CNW –

MUMBAI, India and BRAMPTON, ON, Sept. 24, 2026 /CNW/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, together with its subsidiaries and/or affiliated companies, 'Sun Pharma') today…

thehindubusinessline.com - Pharma revenue growth to accelerate to 11-13% this fiscal: Crisil
Pharma revenue growth to accelerate to 11-13% this fiscal: Crisil
BusinessLine –

Indian pharma revenue growth is expected to accelerate to 11-13 per cent this fiscal from 8 per cent last year, driven by a 14-16 per cent rise in exports as drugmakers expand beyond the US into Europe, Asia, Africa and Latin America, ratings…

marketbeat.com - Insider Selling: Royalty Pharma (NASDAQ:RPRX) EVP Sells $5,853,000.00 in Stock
Insider Selling: Royalty Pharma (NASDAQ:RPRX) EVP Sells $5,853,000.00 in Stock
MarketBeat –

Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report) EVP Christopher Hite sold 100,000 shares of the stock in a transaction on Tuesday, September 22nd. The stock was sold at an average price of $58.53, for a total transaction of $5,853,000.00.

marketbeat.com - Helus Pharma Eyes Q4 Phase III Data for HLP-003 in Major Depression
Helus Pharma Eyes Q4 Phase III Data for HLP-003 in Major Depression
MarketBeat –

Magic Mushrooms, Hard Cash: Compass Pathways' Trial Win, Fast Raise Helus Pharma, formerly known as Cybin NASDAQ: HELP, outlined its late-stage development plans for HLP-003 in adjunctive major depressive disorder (MDD) and discussed its broader…

marketbeat.com - Nuvectis Pharma (NASDAQ:NVCT) Earns 'Buy' Rating from HC Wainwright
Nuvectis Pharma (NASDAQ:NVCT) Earns 'Buy' Rating from HC Wainwright
MarketBeat –

Nuvectis Pharma (NASDAQ:NVCT - Get Free Report)'s stock had its 'buy' rating restated by equities researchers at HC Wainwright in a research note issued to investors on Thursday, Benzinga reports. They presently have a $39.00 price objective on the…

cnbc.com - Alexa LoMonaco - Why we like Starbucks' latest turnaround move - plus, two more wins for Eli Lilly
Why we like Starbucks' latest turnaround move - plus, two more wins for Eli Lilly
CNBC –

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Stocks were mixed Thursday as Treasury yields surged and investors…

globenewswire.com - Roquette Frères - Strategic Transformation Supports Roquette's H1 2026 Performance
Strategic Transformation Supports Roquette's H1 2026 Performance
GlobeNewswire –

Strategic Transformation Supports Roquette's H1 2026 Performance +9% turnover growth to €2,586 million and +18% Current EBITDA increase to €337 million. Performance was supported by favorable volume and mix effects, the continued…

seekingalpha.com - Fidelity Investments - Fidelity Select Health Care Portfolio Q2 2026 Commentary
Fidelity Select Health Care Portfolio Q2 2026 Commentary
Seeking Alpha –

Outperformance was driven by superior stock selection in biotech, pharma, and health care services, with notable contributions from Oruka Therapeutics and strategic positioning in innovative assets. FSPHX is increasing exposure to innovative…

rediff.com - Nandita Malik - Sensex Plunges 600+ Points: Crude Oil Above $100, Global Cues Weigh on Indian Markets
Sensex Plunges 600+ Points: Crude Oil Above $100, Global Cues Weigh on Indian Markets
Rediff.com –

Indian benchmark indices, Sensex and Nifty, witnessed a sharp decline in early trade as crude oil prices surged past $100 per barrel, coupled with weak global market trends, impacting investor sentiment. The BSE Sensex plummeted 632.68 points, and…

marketwatch.com - Eli Lilly, InnoCare Sign Deal That Could Top $3 Billion
Eli Lilly, InnoCare Sign Deal That Could Top $3 Billion
MarketWatch –

InnoCare, a specialist in cancer and autoimmune diseases, will use its proprietary drug-discovery platform to develop new medicines with the U.S. pharma giant. Under the terms of the Thursday agreement, InnoCare will be eligible for up to $100…

globenewswire.com - Boehringer Ingelheim Limited - Boehringer Ingelheim and WHO Foundation launch global collaboration to close the gap in obesity and metabolic health
Boehringer Ingelheim and WHO Foundation launch global collaboration to close the gap in obesity and metabolic health
GlobeNewswire –

Supporting obesity and metabolic health with a USD 5 million contribution from Boehringer Ingelheim over three years Collaboration will strengthen integrated care for obesity and related cardiovascular, kidney, liver and metabolic diseases to…

rediff.com - Rediff News - NSE enters 'top 10 most valued firms' club; shares jump 5%
NSE enters 'top 10 most valued firms' club; shares jump 5%
Rediff.com –

Shares of National Stock Exchange of India Ltd (NSE) jumped over 5 per cent during intraday trade on Thursday after a muted debut and entered the elite club of top-10 most valued firms by market valuation. The exchange started trading at Rs 1,800…

irishtimes.com - Cliff Taylor - Unscrambling Ireland's rollercoaster export figures
Unscrambling Ireland's rollercoaster export figures
The Irish Times –

Ireland's exports to the US fell by 65 per cent in the first half of this year, dropping to €26.2 billion from €75.1 billion in the same period of 2025. It is the latest part of a rollercoaster ride. This scale of fall-off would…

Receive a Daily briefing on Pharma Industry News

Get Started